Promotion of emotional regulation in adults without clinical symptoms or with mild symptoms of psychopathology Mental and Behavioural Disorders
Conditions
Interventions
Eligible participants will be randomized into two conditions: (1) intervention group (IG)
(2) control group (CG). Both groups will complete the same online questionnaires, but the CG group will wait for approximately 4 weeks, being evaluated at 3 times during this waiting time. IG will hav
Sponsors
University of Maia - Portugal
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 65 years old 2. Having an interest in clarifying their emotions 3. Having digital literacy to use internet-based videoconference (Microsoft Teams)
Exclusion criteria
Exclusion criteria: 1. Changes in their therapeutic plan with psychopharmaceuticals in the last month 2. Currently undergoing a psychological treatment 3. Moderate to severe psychopathology 4. Not having internet access and/or conditions to carry out the sessions with privacy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Focusing attitudes assessed using the Focusing Manner Scale (FMS) at T1, T4, and T5 Note. T1 = Evaluation moment before session Nº1; T2 = Evaluation moment at the end of session Nº1; T3 = Evaluation moment before session Nº2; T4 = Moment of evaluation at the end of session Nº2; T5 = Assessment time 15 days after T4 (follow-up). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Positive and negative affect assessed using the Positive and Negative Affect Program (PANAS) at T1, T2, T3, and T4 2. Ability to focus assessed using the Post-Focusing Checklist 2 (PFC-2) at T2 and T4 3. Propensity to use six emotion regulation strategies to decrease their experience of negative emotions: a) distraction, b) rumination, c) reappraisal, d) suppression, e) engagement, and f) arousal control, assessed using the Survey on the Regulation of Emotional Systems (RESS) at T1, T4, and T5 4. Mental health and psychological well-being assessed using the Clinical Outcome Routine Evaluation – Outcome Measure (CORE-OM) at T1, T3, and T5 5. Subjective well-being assessed using the Psychological Well-Being Scale - Short Version (EBEP - VR) at T1 and T5 6. Depressive symptoms assessed using the Patient Health Questionnaire (PHQ-9) at T1, T3, and T5 7. Anxiety symptomatology assessed using the General Anxiety Disorder (GAD-7) at T1, T3, and T5 8. Self-esteem assessed using the Rosenberg Self-Esteem Scale (RSES) at T1 and T5 Note. T1 = Evaluation moment before session Nº1; T2 = Evaluation moment at the end of session Nº1; T3 = Evaluation moment before session Nº2; T4 = Moment of evaluation at the end of session Nº2; T5 = Assessment time 15 days after T4 (follow-up). | — |
Countries
Portugal
Outcome results
None listed